Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October, 2016. Lexaria’s technology provides increases of up to 10x in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits, for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.
#100-740 McCurdy Rd
UPLOAD NEW PRESS RELEASE (log in required)
Log in to upload press releases
LEXARIA BIOSCIENCES Q&A
If you have any questions about Lexaria Biosciences or any of their products, please post them here.